LONG-TERM UPREGULATION OF MIR-124 IN BLOOD AND RECTAL BIOPSIES OF PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS RECEIVING OBEFAZIMOD 50 MG DAILY FOR 96-WEEKS

Julien Santo  ¹     Aurélien Flatres  ¹     Paul GINESTE  ²     Didier scherrer  ²     Josianne Nitcheu  ²     Sheldon Sloan  ²     Hartmut Ehrlich  ²     Bruce E. Sands  ³     Severine Vermeire  ^4    
1 Abivax, Montpellier, France
² Abivax, Paris, France
³ Icahn School of Medicine at Mount Sinai, New York, United States
⁴ University Hospitals Leuven, Leuven, Belgium

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)